Literature DB >> 2667473

Reversal of hypersplenism following orthotopic liver transplantation.

K Yanaga1, A G Tzakis, M Shimada, W E Campbell, J W Marsh, A C Stieber, L Makowka, S Todo, R D Gordon, S Iwatsuki.   

Abstract

The purpose of this study was to clarify the effect of orthotopic liver transplantation on hypersplenism. In a 1-year period from July 1, 1986 to June 30, 1987, 196 adult patients underwent 233 orthotopic liver transplantations. Of the 58 patients with hypersplenism who were analyzed in this study, hypersplenism was more commonly associated with postnecrotic cirrhosis than other kinds of liver disease (55.3% (47/85) vs. 14.5% (11/76); p less than 0.001). Postoperative platelet counts were statistically higher than preoperative values (p less than 0.05). The latest platelet counts were more than 100,000/mm3 in 53 patients (91.4%). Of the eight patients whose preoperative and postoperative spleen volumes could be compared, all showed the reduction in the spleen size (p less than 0.02). We conclude that orthotopic liver transplantation, which is a radical surgical procedure for portal hypertension, reverses hypersplenism.

Entities:  

Mesh:

Year:  1989        PMID: 2667473      PMCID: PMC1357825          DOI: 10.1097/00000658-198908000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Effect of portasystemic shunt on hypersplenism: clinical study in 129 patients with cirrhosis.

Authors:  M Puttini; A Marni; F Montes; L Belli
Journal:  Am Surg       Date:  1979-07       Impact factor: 0.688

2.  Platelet changes following clinical and experimental hepatic homotransplantation.

Authors:  D E Hutchison; E Genton; K A Porter; P M Daloze; C Huguet; L Brettschneider; C G Groth; T E Starzl
Journal:  Arch Surg       Date:  1968-07

3.  The effect of portacaval shunt on hypersplenism.

Authors:  W R Felix; R M Myerson; B Sigel; E B Perrin; F C Jackson
Journal:  Surg Gynecol Obstet       Date:  1974-12

4.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

5.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

6.  [Exercise therapy for patients with acute myocardial infarct under strict and less-restricted confinement to bed].

Authors:  N A Gukasova
Journal:  Med Sestra       Date:  1972-02

7.  Results of a modified distal spleno-renal shunt for portal hypertension.

Authors:  J Vang; G Simert; J A Hansson; U Thylen; T S Bengmark
Journal:  Ann Surg       Date:  1977-02       Impact factor: 12.969

8.  The effect of the distal splenorenal shunt on hypersplenism.

Authors:  D G Hutson; R Zeppa; J U Levi; E R Schiff; A S Livingstone; P Fink
Journal:  Ann Surg       Date:  1977-05       Impact factor: 12.969

9.  Correction of hypersplenism following distal splenorenal shunt.

Authors:  J Ferrara; E C Ellison; E W Martin; M Cooperman
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982

10.  Effect of portacaval anastomosis on hypersplenism.

Authors:  M G Mutchnick; E Lerner; H O Conn
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

View more
  17 in total

1.  Changes in splenic volume during liver regeneration.

Authors:  Hideya Ando; Masato Nagino; Toshiyuki Arai; Hideki Nishio; Yuji Nimura
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 2.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Effect of liver transplantation on spleen size, collateral veins, and platelet counts.

Authors:  Fumio Chikamori; Seigo Nishida; Gennaro Selvaggi; Panagiotis Tryphonopoulos; Jang I Moon; David M Levi; Tomoaki Kato; Eddie R Island; Akira Maki; Akin Tekin; Andreas G Tzakis
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

4.  Effect of severe thrombocytopenia on patient outcome after liver transplantation.

Authors:  Chaker Ben Hamida; Jean-Yves Lauzet; Saida Rézaiguia-Delclaux; Christophe Duvoux; Daniel Cherqui; Philippe Duvaldestin; François Stéphan
Journal:  Intensive Care Med       Date:  2003-04-03       Impact factor: 17.440

5.  Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation.

Authors:  J Goulis; T N Chau; S Jordan; A B Mehta; A Watkinson; K Rolles; A K Burroughs
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.

Authors:  Omar I Massoud; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

7.  Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.

Authors:  Z Karasu; A Gurakar; B Kerwin; S Hulagu; A Jazzar; R McFadden; B Nour; A Sebastian; F Cassidy; K Stokes; D H Van Thiel; H Wright
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

8.  Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?

Authors:  N Jabbour; A Zajko; P Orons; W Irish; J J Fung; R R Selby
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

9.  Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

10.  Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy.

Authors:  A Sidney Barritt; Michael W Fried; Paul H Hayashi
Journal:  Dig Dis Sci       Date:  2009-08-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.